Tag: Clinical trials
Medicaid Coverage of Obesity Drugs and Sickle Cell Trial Death: Pharmalittle Update
Good morning, everyone! We hope you're having a great day. Despite the cloudy skies here at Pharmalot, we're doing well and enjoying the autumn breeze. Today is an exciting day with millions of voters...
Assessing the Cost-Effectiveness of Alzheimer’s Drug Donanemab in the U.K.
The recent decision by the U.K.'s National Institute for Health and Care Excellence (NICE) regarding the cost-effectiveness of the Alzheimer's drug Donanemab, also known as Kisunla, has raised concerns about its accessibility to patients....
The Impact of MDMA-Assisted Psychotherapy: Challenges and Progress
A tough weekend for those supporting MDMA-assisted psychotherapy. First, the FDA rejects a treatment from Lykos Therapeutics. Now a journal is retracting three MDMA papers due to data integrity issues. In contrast, a nasal...
New Hope for Endometrial Cancer Patients with FDA-Approved Immunotherapy
The U.S. Food and Drug Administration (FDA) recently approved a new drug for certain adult patients with endometrial cancer. The drug, called Jemperli (dostarlimab-gxly), is an immunotherapy-based drug made by British pharmaceutical company GSK....
FDA Rejects MDMA and Nasal Spray for Allergic Reactions: Pharmalittle Update
Good morning everyone, hope you had a restful weekend and are ready to tackle the new week ahead. As we sip on some refreshing blueberry cobbler, let's dive into some interesting updates. The U.S....
MDMA Therapy Papers Retracted Due to Data Integrity Concerns
The journal Psychopharmacology has retracted three papers about MDMA-assisted psychotherapy due to data integrity concerns. These papers were published in 2020 and 2021, and many authors were affiliated with the nonprofit Multidisciplinary Association for...
FDA Requests Further Research before Approving MDMA Therapy
The Food and Drug Administration (FDA) recently declined to approve MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD), citing insufficient data to support its use. The FDA requested additional clinical trials to...
MDMA Trials and Weight Loss Drug Availability: Pharmalittle Updates
Good morning, everyone! It's a new week, and we hope you're ready to tackle whatever challenges come your way. The world keeps spinning, and we're here to help you stay informed. So grab your...
Accurate Alzheimer’s Diagnosis: Blood Test with 90% Success Rate
Scientists have recently made a significant advancement in the quest for a simple blood test to accurately diagnose Alzheimer's disease. The study, published in the journal JAMA, revealed that the blood test was approximately...
New Title: Soft-Tissue Cancer Drug Approval and Zepbound Shortage Update: Pharmalittle News
Good morning, this is Jonathan Wosen, reporting on the latest news in the biotech and life sciences world. The FDA has recently approved a new treatment for a rare soft tissue cancer. This cutting-edge...